L forms, spheroplasts and aberrant forms in chronic sepsis.
D000368:Aged; D001161:Arteriosclerosis / Q000382:microbiology; D002473:Cell Wall / Q000187:drug effects; D003454:Cryptococcus / Q000472:pathogenicity; D004492:Edetic Acid / Q000494:pharmacology; D004697:Endocarditis, Bacterial / Q000382:microbiology; D004926:Escherichia coli / Q000472:pathogenicity; D006192:Haemophilus Infections / Q000382:microbiology; D006801:Humans; D007111:Immunity, Cellular; D007740:L Forms / Q000187:drug effects / Q000302:isolation & purification / Q000472:pathogenicity*; D008248:Lysostaphin / Q000494:pharmacology; D008297:Male; D010406:Penicillins / Q000627:therapeutic use; D011523:Protoplasts; D012475:Salmonella / Q000472:pathogenicity; D018805:Sepsis / Q000382:microbiology*; D013104:Spheroplasts; D013280:Stomatitis / Q000382:microbiology; D013290:Streptococcal Infections / Q000382:microbiology; D013752:Tetracycline / Q000627:therapeutic use; D013924:Thrombophlebitis / Q000382:microbiology; D014552:Urinary Tract Infections / Q000382:microbiology; D008061:Whipple Disease / Q000382:microbiology
D010406:Penicillins; D004492:Edetic Acid; D008248:Lysostaphin; D013752:Tetracycline